Vaxart Inc
NASDAQ:VXRT
| Market Cap (Intraday) | 748.26M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $7.56 |
| 50-Day MA | $8.05 |
| 200-Day MA | $7.07 |
Vaxart, Inc. Stock, NASDAQ:VXRT
385 Oyster Point Boulevard, Suite 9A, South San Francisco, California 94080
United States of America
Phone: +1.650.550.3500
Number of Employees: 14
Description
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.